Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0SK1W
|
||||
| Former ID |
DIB005965
|
||||
| Drug Name |
AS-602305
|
||||
| Synonyms |
AS-602305; AS-603831; Oxytocin receptor antagonists (premature labor); Oxytocin receptor antagonists (premature labor), Merck Serono; Oxytocin receptor antagonists (premature labor), Serono
|
||||
| Indication | Androgen decline [ICD10:E20-E35] | Terminated | [1] | ||
| Company |
Merck Serono SA
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
N1(C(=O)c2ccc(c3c(C)cccc3)cc2)[C@H](C(=O)NC[C@H](c2cccc<br />c2)O)C/C(=N/OC)/C1
|
||||
| CAS Number |
CAS 364071-17-0
|
||||
| Target and Pathway | |||||
| Target(s) | Oxytocin receptor | Target Info | Antagonist | [2] | |
| KEGG Pathway | Calcium signaling pathway | ||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Oxytocin signaling pathway | |||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| PANTHER Pathway | Oxytocin receptor mediated signaling pathway | ||||
| Reactome | Vasopressin-like receptors | ||||
| G alpha (q) signalling events | |||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
| Myometrial Relaxation and Contraction Pathways | |||||
| Oxytocin signaling | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| Peptide GPCRs | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020775) | ||||
| REF 2 | Clinical pipeline report, company report or official report of darkpharma. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.